Glaxo, Shionogi Say HIV Drug Beats Gilead Atripla in Test

GlaxoSmithKline Plc marketed the first HIV drug a quarter century ago before losing out to Gilead Sciences Inc. as the world’s biggest maker of AIDS medicines. Now Glaxo is staging a comeback.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.